Is a complete MTNB research report available?

No complete published report is available for Matinas BioPharma Holdings, Inc. (MTNB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Matinas BioPharma Holdings, Inc. (MTNB)

NYSEAMERICAN: MTNB · USD

$0.24

-0.01 (-3.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MTNB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.5M
Net income (ttm)	-11.2M
EPS (ttm)	-$1.93
Shares out	6.4M
Volume	33,827,313
Beta	1.71

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -11.2M
EPS (ttm): -$1.93
Market cap: 1.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MTNB indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001582554
Company name	Matinas BioPharma Holdings, Inc.
Country	United States
Country code	US
Cusip	576810303
Employees	2
Employees Change	-1%
Employees Change Percent	-33.33
Enterprise value	$337,455
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US5768103039
Last refreshed	2026-07-25
Market cap	$1.5M
Market cap category	Nano-Cap
Price	$0.24
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	MTNB
Website	https://www.matinasbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-726.05%
FCF yield	-427.11%
P/B ratio	0.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-11.2M
Net Income Growth Years	1%
Profit Per Employee	$-5.6M
ROA	-48.51
Roa5y	-41.08
ROCE	-185.4
ROE	-228.4
Roe5y	-103.3
ROIC	-65.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-38.54%
Cagr1y	-74.61%
Cagr3y	-77.05%
Cagr5y	-63.24%
EPS Growth Quarters	5
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$5.9M
Cash	$2.4M
Current Assets	$2.8M
Current Liabilities	$2.1M
Debt	$1.2M
Debt Equity	$0.39
Equity	$3M
Interest Coverage	-6,950
Liabilities	$2.9M
Long Term Assets	$3.1M
Long Term Liabilities	$726,000
Net Cash	$1.2M
Net Cash By Market Cap	$78.18
Net Cash Growth	-71.28%
Net Debt Equity	$-0.4
Tangible Book Value	$3M
Tangible Book Value Per Share	$0.47
WACC	7.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.32
Net Working Capital	$-989,000
Quick ratio	1.13
Working Capital	$689,000

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.91%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.23%
1Y total return	-74.59%
200-day SMA	0.77
3Y total return	-98.79%
50-day SMA	0.62
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.33%
All Time High	199.5
All Time High Change	-99.88%
All Time High Date	2017-03-02
All Time Low	0.23
All Time Low Change	4.41%
All Time Low Date	2026-07-24
ATR	0.07
Beta	1.71
Beta1y	2.24
Beta2y	1.93
Ch YTD	-58.81
High	0.27
High52	3.09
High52 Date	2025-08-15
High52ch	-92.19%
Low	0.23
Low52	0.23
Low52 Date	2026-07-24
Low52ch	4.41%
Ma50ch	-60.9%
Premarket Change Percent	4.58
Premarket Price	$0.26
Premarket Volume	2,597
Price vs 200-day SMA	-68.57%
RSI	25.02
RSI Monthly	33.29
RSI Weekly	32.95
Sharpe ratio	-0.47x
Sortino ratio	-0.64
Total Return	-14.91%
Tr YTD	-58.81
Tr1m	-62.87%
Tr1w	-29.74%
Tr3m	-60.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,180,280%
Float Percent	65.25%
Net Borrowing	-8,000
Shares Insiders	11.49%
Shares Institutions	6.37%
Shares Out	6,406,191
Shares Qo Q	1.96%
Shares Yo Y	14.91%
Short Float	0.15%
Short Ratio	0.09
Short Shares	0.1

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.4M
Average Volume	1,046,941.95x
Bv Per Share	0.47
Ch10y	-99.23
Ch1m	-62.87
Ch1w	-29.74
Ch1y	-74.59
Ch3m	-60.88
Ch3y	-98.79
Ch5y	-99.33
Ch6m	-66.47
Change	-3.13%
Change From Open	-3.59
Close	0.25
Days Gap	0.48
Depreciation Amortization	26,000
Dollar Volume	8,165,913.4
Earnings Date	2026-05-08
Earnings Time	amc
EBIT	$-7M
EBITDA	$-6.9M
EPS	$-1.93
F Score	1
FCF	$-6.6M
FCF EV Yield	-1,957.3x
FCF Per Share	$-1.03
Financing CF	1,744,000
Fiscal Year End	December
Founded	2,013
Investing CF	335,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2024-09-03
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	0.62
Ma150ch	-60.89%
Ma20	0.48
Ma20ch	-49.99%
Net CF	-4,526,000
Open	0.25
Optionable	No
Position In Range	28.49
Post Close	0.24
Postmarket Change Percent	40.43
Postmarket Price	$0.34
Ppne	599,000
Pre Close	0.25
Price Date	2026-07-24
Ptbv Ratio	0.51
Relative Volume	32.31x
Share Based Comp	821,000
Tr6m	-66.47%
Us State	New Jersey
Views	160
Volume	33,827,313

Matinas BioPharma Holdings, Inc. (MTNB)

Coverage state: Market snapshot only — no published research

Generate the first MTNB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · MTNB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MTNB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MTNB

Frequently asked questions